Switching from Premixed Insulin to Insulin Degludec/Insulin Aspart for the Management of Type 2 Diabetes Mellitus: Implications of a Real-World Study on Insulin Degludec Dosing
In the setting of transition to IDegAsp from premixed insulin, the dose of basal insulin in the premixed formulation can be a valuable reference for adjusting insulin degludec dose. IDegAsp is superior to premixed insulin in blood glucose control with reduced total daily dose and injection frequency. IDegAsp could be the best choice for the management of diabetes in elderly patients.
Authors
- Ang Li (ORCID: https://orcid.org/0000-0003-0971-6534)
- Junqing Zhang (ORCID: https://orcid.org/0000-0002-8574-1945)
- Yiming Wu (ORCID: https://orcid.org/0000-0001-5498-7048)
Institutions
- Peking University (CN)
- Peking University First Hospital (CN)
Publication Details
- Journal
- Diabetes Therapy
- Published
- 2024-10-26
- DOI
- https://doi.org/10.1007/s13300-024-01663-x
- Citations
- 2
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.72